SORRY - THIS PRODUCT IS DISCONTINUED
go to other Evening Primrose Oil products
The DriCelle process provides allows large doses of
essential nutritional oils to be taken in a palatable powder form with
enhanced absorption and bio-availability. DriCelle EPO provides 90mg of
GLA gamma linolenic acid.
Additional Information
-
DriCelle® Evening Primrose Oil mixed into
water produces a pleasant tasting effervescent lemon drink
-
More convenient than taking large numbers
of capsules
-
DriCelle® Evening Primrose Oil provides
Omega-6 essential fatty acids in the form of micellised,
bioavailable cold-pressed evening primrose oil
-
Essential fatty acids help support skin,
heart, circulation and nerve function
-
GLA may support hormones pre-menstrually
-
Contains additional antioxidants vitamin E
and vitamin C to enhance stability, and is vacuum packed to
maintain freshness and protect the delicate oils from oxidation
-
Suitable for children from 2 years of age
-
BioCare Dricell Evening Primrose Oil is
suitable for Children, during Pregnancy, whilst breastfeeding,
for Vegetarians and Vegans
Product Information per Daily Intake
DriCelle Evening Primrose Oil 660mg - providing approx.
90 mg linolenic acid (GLA)
Vitamin C 90mg
Vitamin E 90 iu 60mg
vitamin B2 4mg
Ingredients:
Fructose, Potato Maltodextrin, Modified Tapioca Starch, Evening
Primrose Oil, Potassium Bicarbonate, Lemon Puree, Citric Acid,
Vitamin C (as Ascorbic Acid), Vitamin E (as D-Alpha Tocopherol
Acetate), Lemon Oil, Antioxidants (Ascorbic Acid, Ascorbyl Palmitate
& Natural Mixed Tocopherols), Vitamin B2 (as Riboflavin-5-Phosphate
Sodium), Sunflower Oil.
Recommended Intake
One scoop (approx 4 grams) mixed in water, juice or milk taken daily
with food or as professionally directed. For children aged 2-4:1/4
scoop daily, aged 5-13:1/2 scoop daily.
Warnings
Not suitable for individuals taking anti-blood clotting medication
such as Warfarin, Coumarin or Heparin
Not suitable for individuals suffering from epilepsy
Benefits of Evening Primrose Oil
In his book 'Fats and Oils' Udo Erasmus
confirms that "oil of evening primrose has been extensively tested in
double blind trials in hospital settings on several continents, and an
impressive list of its therapeutic successes in many diseases has
accumulated".
He reports that oil of evening primrose
"has been used successfully to lower blood pressure, to lower blood
cholesterol level, and thereby to decrease the risk of cardiovascular
accident (stroke and heart attack)".
He continues "Oil of evening primrose
prevents liver damage due to alcoholism, prevents the withdrawal
symptoms when the habitual use of alcohol is discontinued, and prevents
the hangovers which so often spoil the morning after the party."
He further mentions that "Oil of evening
primrose is a useful adjunct in the treatment of schizophrenia, because
schizophrenics have very low levels of prostaglandin E1, the most
important of several prostaglandins made from GLA. When the level of
prostaglandins increased by the administration of oil of evening
primrose, some improvement was noted, especially in schizophrenics whose
disease had been of less than 5 years' duration."
Udo Erasmus states in his book 'Fats and
Oils' that evening primrose oil has been used for weight loss, because
it increases the metabolic rate, and therefore the burn-off of fat,
without special dieting.
A well-known use for evening primrose oil
has been premenstrual syndrome, particularly breast pain (mastalgia). He
states that it is so effective and so safe, that the doctors who did the
studies in Britain and Wales now use it as the treatment of first choice
for premenstrual breast pain. Other premenstrual symptoms, such as
bloating, irritability and depression are also treated in the UK with
oil of primrose.
Research
Ishikawa T, Fujiyama Y, Igarashi O, et al.
Effects of gammalinolenic acid on plasma lipoproteins and
apolipoproteins. Atherosclerosis 1989;75:95-104
Yoshimoto-Furuie K, Yoshimoto K, Tanaka T,
et al. Effects of oral supplementation with evening primrose oil for six
weeks on plasma essential fatty acids and uremic skin symptoms in
hemodialysis patients. Nephron 1999;81:151-9.
Tamimi NA, Mikhail AI, Stevens PE. Role of
gamma-linolenic acid in uraemic pruritus. Nephron 1999;83:170-1
[letter].
Horrobin DF. The importance of gamma-linolenic
acid and prostaglandin E1 in human nutrition and medicine. J
Holistic Med 1981;3:118-39.
Horrobin DF, Manku M, Brush M, et al.
Abnormalities in plasma essential fatty acid levels in women with
pre-menstrual syndrome and with non-malignant breast disease. J Nutr
Med 1991;2:259–64
Manku MS, Horrobin, DF, Morse NL, et al.
Essential fatty acids in the plasma phospholipids of patients with
atopic eczema. Br J Derm 1984;110:643.
Horrobin DF. Essential fatty acids in
clinical dermatology. J Am Acad Dermatol 1989;20:1045–53.
Mansel RE, Pye JK, Hughes LE. Effects of
essential fatty acids on cyclical mastalgia and noncyclical breast
disorders. In Omega-6 Essential Fatty Acids: Pathophysiology and
Roles in Clinical Medicine, ed. DF Horrobin. New York: Alan R Liss,
1990, 557–66.
Keen H, Payan J, Allawi J, et al.
Treatment of diabetic neuropathy with gamma-linolenic acid. Diabetes
Care 1993;16:8–15.
Horrobin DF. Essential fatty acid
metabolism in diseases of connective tissue with special reference to
scleroderma and to Sjogren’s syndrome. Med Hypotheses
1984;14:233–47.
Vaddadi KS, Gilleard CJ. Essential fatty
acids, tardive dyskinesia, and schizophrenia. In Omega-6 Essential
Fatty Acids: Pathophysiology and Roles in Clinical Medicine.
Horrobin DF (ed). New York: Alan R Liss, 1990, 333–43.
Schalin-Karrila M, Mattila L, Jansen CT,
et al. Evening primrose oil in the treatment of atopic eczema: effect on
clinical status, plasma phospholipid fatty acids and circulating blood
prostaglandins. Br J Dermatol 1987;117:11–9